Home » family planning method » Recent Articles:

Opinions: Future Of PEPFAR; Family Planning

December 15, 2009 Health News No Comments

A Washington Post editorial examines the future of PEPFAR under the Obama administration, as outlined in a five-year strategy released earlier this month. Though “[m]any organizations, including Doctors Without Borders, continue to worry that Mr. Obama is ‘flat-lining’ funding for the vital program,” this “ignores Mr. Obama’s move to make PEPFAR the center of a larger $63 billion global health initiative to develop more comprehensive and integrated approaches to care,” the editorial writes. “To that end, PEPFAR 2 has three pillars: prevention, integration and improved health-care systems in the 15 participating countries…”

“Ultimately, the goal is to shift to… Continue reading

Relationship Between Family Planning, Women’s Health And Climate Change

November 20, 2009 Health News No Comments

“Providing access to contraception for 215 million women, mainly in developing countries, would help to stabilize population growth and significantly reduce the effects of climate change,” according to a report released Wednesday by the United Nations Population Fund (UNFPA), Nature News reports (Gilbert, 11/18).

[/caption]

In the “State of the World Population 2009″ report, UNFPA “argues that international agreements and national policies on climate change are more likely to succeed if they take into account population dynamics, the relations between the sexes, and women’s wellbeing and access to healthcare services,” BMJ News reports. The report also “warns that… Continue reading

ADS:

Featured Content:

Growth Of Chronic Kidney Disease Highlights Need For Early Detection, Greater Knowledge Of Treatment Options

March 12, 2010

As the incidence of diabetes and hypertension continues to grow worldwide – and increasing numbers of patients progressing to kidney disease and kidney failure place a financial strain on public health systems – the need for early patient education about kidney disease and treatment options, including home-based treatments, has become critical. More than 240 million people have diabetes and this figure is projected to rise to 380 million by 20251. In the United States alone, 17.9 million have been diagnosed with diabetes resulting in medical and indirect costs (e.g…

Go to Source… Continue reading

Medicine Shoppe And Medicap Pharmacy Statement On Franchisee Lawsuit

March 12, 2010

Terry Burnside, general manager and senior vice president responsible for Medicine Shoppe and Medicap Pharmacy operations, today issued the following statement in response to a lawsuit filed in U.S. District Court in the Southern District of Ohio by seven Medicine Shoppe and Medicap franchisees, purporting to represent a class: Medicine Shoppe is dedicated to serving the needs of retail pharmacies and to helping them succeed. This has been true since 1970 when we began, and it is a value we hold sacred today…

Go to Source… Continue reading

Boston Scientific Announces Schedule For ACC 2010

March 12, 2010

Boston Scientific Corporation (NYSE: BSX) announced the schedule of the Company’s major events and news announcements at the 59th Annual Scientific Session of the American College of Cardiology/i2 Summit, March 13-16 in Atlanta. “We look forward to announcing 12-month results from the PERSEUS clinical program, which will provide important data on our third-generation drug-eluting stent, the TAXUS® Element™ Paclitaxel-Eluting Stent,” said Keith Dawkins, M.D., Senior Vice President and Chief Medical Officer for Boston Scientific…

Go to Source… Continue reading

Cancer Patients In Kent Gain Access To Advanced RapidArc(R) Radiotherapy Treatments From Varian

March 12, 2010

Cancer patients in Kent will gain access to advanced radiotherapy treatments with the decision by the Kent Oncology Centre to acquire two fully-equipped treatment machines from Varian Medical Systems (NYSE: VAR). The machines, due to be delivered to oncology departments in Maidstone and Canterbury in the spring, will mean these departments are among the first in the country to offer fast and efficient RapidArc® radiotherapy treatments…

Go to Source… Continue reading

Leading Varian-Equipped Proton Therapy Center Treats 100th Patient

March 12, 2010

Clinicians at the Rinecker Proton Therapy Center (RPTC) in Munich have treated their 100th patient using advanced proton therapy systems supplied by Varian Medical Systems (NYSE: VAR). The landmark treatment comes just three months after a second treatment gantry was commissioned at the center, which offers advanced pencil-beam proton scanning to cancer patients. These patients, requiring treatment for a wide range of cancers, have come from across Germany and 19 other countries, including Canada, Argentina, the UK and Switzerland…

Go to Source… Continue reading

AstraZeneca Comments On FDA Joint Advisory Committee Meeting On Post-Marketing Safety Studies For The Use Of LABAs In Asthma

March 12, 2010

On March 10-11, 2010, the Joint Advisory Committees of the U.S. Food and Drug Administration (FDA) — including the Pulmonary-Allergy Drugs and the Drug Safety and Risk Management Advisory Committees — discussed the design of post-marketing safety studies for long-acting beta-agonist (LABA)-containing products in the U.S., including SYMBICORT® (budesonide/formoterol fumarate dihydrate)…

Go to Source… Continue reading

The Results Are In: Users Of BodyMedia’s Wearable Body-Monitoring Technology Lose 3 Times More Weight

March 12, 2010

With obesity in America reaching alarming levels — across our adult and youth populations — results from a clinical trial unveiled by BodyMedia confirm that participants who used BodyMedia’s wearable body-monitoring technology either in conjunction with a group weight loss program or as part of their own self-directed program lost up to three times more weight than individuals who attempted to battle the bulge solo. BodyMedia Inc…

Go to Source… Continue reading

Newly-Published Study Reinforces Role Of Antiepileptic Drug Vimpat(R) (lacosamide) (C-V) As An Add-on Treatment That Significantly Reduces Epilepsy

March 12, 2010

UCB announced that the antiepileptic drug (AED) Vimpat® (lacosamide) (C-V) demonstrated significantly fewer partial-onset seizures versus placebo in adults living with epilepsy, according to a Phase III clinical study published online in Epilepsia. This study was one of three that supported the approval of Vimpat by the U.S. Food and Drug Administration (FDA) in 2008 for use as an add-on therapy for the treatment of partial-onset seizures in people with epilepsy who are 17 years and older. Previous studies have demonstrated that Vimpat has a novel mechanism of action…

Go to Source… Continue reading

Recent Comments:

  • symptoms of dementia: What's the difference between dementia and Alzheimers? what is the difference? I think my father may be suffering one of these? does anyone know the w...
  • rani: good blog thank 4 the info...
  • JourneyHome: McCarran-Ferguson was originally designed to empower both the federal government and the individual states so that they could act to prevent insurance...
  • Hydro Closet: Hi, I thought I would say you have a wonderful site and rich content. I bookmarked your site and have it in my reader now...looking forward to future ...
  • Allan Ono: Getting more usage from drugs already approved by the FDA for new indications seems like a very good way to expand treatment options without the hyper...